2019. February 6. FDA. Statement from Binita Ashar, M.D., of the FDA’s Center for Devices and Radiological Health on agency’s continuing efforts to educate patients on known risk of lymphoma from breast implants
2017. March. Harvard. Nonhormonal treatments for menopause
2017. March 28. Medscape. BRCA testing has skyrocketed, but misses high risk women
2017. March 28. Chatelaine. Women’s College Hospital wants to screen more people for the breast cancer gene
2017. March 27. Science Daily. Major genetic study identifies 12 new genetic variants for ovarian cancer
2017. February 15. Forbes. The Privacy Delusions of Genetic Testing
2017. February 14. CBC News. Clinical trial for pancreatic cancer treatment to start after Ontario mayor's push
2017. February 13. c&en. CRISPR's breakthrough problem.
2017. February 7. Today. Breast in a Day: New surgery option for women who undergo a mastectomy
2017. February 6. Stanford. Physicians fail to recommend genetic testing to many high-risk breast cancer patients
2017. February 6. New Scientist. Blood test could catch pancreatic cancer before it's too late
2017. February 1. The Globe and Mail. Donation drop forces merger of Canada's largest charities.
2017. February 1. Medscape. Use of Systemic Hormone Therapy in BRCA Mutation Carriers
2017. February 1. SBS News. Ovarian cancer drug most significant PBS listing in 30 years
2017. February 1. The Irish Times. Juggling 10 cancer diagnoses, writing a dozen books and raising a family
2017. February 1. URO Today. Genetic Evaluation for Prostate Cancer Risk: Implications for Urologic Providers: Beyond the Abstracts
2017. January 31. EurekAlert. Changes in gene contribute independently to breast and ovarian cancer
2017. January 28. the Guardian. How breast cancer and the BRCA gene brought us the sister we never knew
2017. January 28. Hisbreastcancer. My Fourth Suspicious Journey with Breast Cancer
2017. January 26. The Jerusalem Post. Life, life, life: Check it out
2017. January 25. Science Daily. Murine study finds potential boost for ovarian cancer drug Olaparib
2017. January 24. NIH. Find and Replace: DNA Editing Tool Shows Gene Therapy Promise
2017. January 23. Oncology Nurse Advisor. Customers Find Useful Information in Results from Direct-to-Consumer Genetic Testing
2017. January 19. Yahoo Finance. Ambry Genetics’ Big Data Sharing Program Now Available for Public Download
2017. January 17. RareDR. Tesaro Opens Expanded Access Program of PARP inhibitor for U.S. Ovarian Cancer Patients
2017. January 14. ynet. Stigmas hold back Israel's war on cancer
2017. January 10. The Hill Times. Genetic discrimination bill headed back to Senate, Liberals deny it reopens possibility for government changes
2017. January 10. OncLive. BRCA Gene Does Not Predict Poor Prognosis in Patients With Breast Cancer?
NOTE: Since its discovery in 1995, this type of hereditary cancer has changed from one type of cancer, caused by mutations in only one gene to several types of cancer, caused by mutations in any of many different genes. As a result, all labels used to describe this syndrome, such as ''breast cancer gene'', ''BRCA'', ''hereditary breast and ovarian cancer'' and ''HBOC'' tell only part of the story, leaving out well over half of those who are affected. To better serve our patient group, we are in the process of changing our name and updating all resources to reflect the fully inclusive and future forward RISKY GENES™ brand. We ask for your patience during this process.